CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares.

On June 12, 2026, Progyny Inc (PGNY) shares rose 3.8% to $26.63. The stock has traded within a 52-week range of $16.10 to $28.75, indicating considerable volati

Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings.

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.

On May 21, 2026, Progyny Inc (PGNY) shares fell 3.8%, closing at $24.69. This decline comes amidst a 52-week range where the stock has seen a high of $28.75 and

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript

For growth investors seeking exposure to a differentiated healthcare disruptor with strong secular tailwinds, Progyny (PGNY) stock deserves a close look.

Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

These highly ranked medical stocks have been capitalizing on their sales expansion, and their defensive or secular growth profiles could become even more attractive if an economic downturn emerges.